Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Inflammatory Bowel Disease

Published:2005-09-01 Issue:9 Volume:26 Page:314-320
ISSN:0191-9601
Container-title:Pediatrics In Review
language:en
Short-container-title:

Author:

Hyams Jeffrey S.¹

Affiliation:

1. Head, Division of Digestive Diseases and Nutrition, Connecticut Children’s Medical Center, Hartford, Conn.; Professor, Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Conn

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatricsinreview/article-pdf/26/9/314/993188/zpx60905000314.pdf

Reference6 articles.

1. Focht DR. Depression in children with inflammatory bowel disease. AAP Grand Rounds. 2005;13:8–9. Commentary on Szigethy E, Levy-Warren A, Whitton S, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr. 1002;39:395–403

2. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15:80–91

3. Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr. 1994;19:7–21

4. Hyams JS, Markowitz JF. Can we alter the natural history of Crohn disease in children?J Pediatr Gastroenterol Nutr. 2005;40:262–272

5. Kim S, Ferry G. Inflammatory bowel diseases in children. Curr Probl Pediatr. 2002;32:103–132

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual biological therapy and small molecules in pediatric inflammatory bowel disease;Pharmacological Research;2023-10

2. Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn’s Disease Patients;Gut and Liver;2022-01-15